Clinical Trial Update: Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating uninterrupted direct-acting oral anticoagulation during transradial percutaneous coronary procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Hospital Universitario La Fe | Conditions: Coronary Artery Disease, Bleeding | Phase 4 | Status: UNKNOWN